TECH ข่าวฟอเร็กซ์

Bio-Techne Q2 Results Miss Estimates; Declares Dividend

Bio-Techne Q2 Results Miss Estimates; Declares Dividend

Life sciences company Bio-Techne Corp. (TECH) reported Thursday that second-quarter net earnings attributable to the company almost halved to $27.47 million or $0.17 per share from $50.01 million or $0.31 per share in the prior-year quarter.
RTTNews | 328 วันที่ผ่านมา
Bio-Techne Files Drug Master File With FDA For ExCellerate GMP IPSC Expansion Medium

Bio-Techne Files Drug Master File With FDA For ExCellerate GMP IPSC Expansion Medium

Bio-Techne Corp. (TECH) announced Wednesday that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ExCellerate GMP iPSC Expansion Medium, Animal Free (CCM0036-GMP), supporting the development and manufacture of regenerative medicine and stem cell therapies.
RTTNews | 371 วันที่ผ่านมา
Bio-Techne To Acquire Namocell For Undisclosed Terms

Bio-Techne To Acquire Namocell For Undisclosed Terms

Life sciences company Bio-Techne Corp. (TECH) announced Wednesday it has reached an agreement to acquire Namocell, Inc., a provider of fast and easy to use single cell sorting and dispensing platforms that are gentle to cells, and preserve cell viability and integrity.
RTTNews | 917 วันที่ผ่านมา